LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the U.S. Food Drug Administration (FDA) has authorized marketing of ...
This can make treatment significantly easier for those affected. It is still possible to participate in the study. Age-related macular degeneration (AMD) is the most common cause of vision loss in ...
Florida Retina Specialists is expanding treatment options for patients with dry age-related macular degeneration by offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results